Penguin Solutions: Growth Momentum Still On Track (NASDAQ:PENG)

This article was written by Follow I’m a passionate investor with a strong foundation in fundamental…

Dell Technologies Stock: This Capitulation May Be Your Chance

This article was written by Follow Daniel Sereda is chief investment analyst at a family office…

Engaged Capital and Yeti reach a key agreement – Three ways to create value

Yeti tumblers are displayed at an REI store on May 09, 2024 in Berkeley, California.  Justin…

6 Dividend Growth Stocks I’m Buying As Tariffs Crush The Economy

This article was written by Follow Austin Rogers is a REIT specialist with a professional background…

What Moved Markets This Week

Seeking Alpha’s Calls Of The Week Strong Buy Rating For Rivian Automotive (RIVN): Trump Tariffs Silver…

From Enbridge To Enterprise Products Partners: I Just Optimized My Portfolio (NYSE:EPD)

This article was written by Follow Dividend Sensei (Adam Galas) is an Army veteran and stock…

Otis Worldwide: Cautiously Optimistic Approaching Earnings (Rating Upgrade) (NYSE:OTIS)

This article was written by Follow I am an investment professional with a background in both…

VLU ETF: A Smarter Value Approach To Long-Term Returns (NYSEARCA:VLU)

This article was written by Follow I am a value focused investor. Stocks rise and fall…

RTX Corporation Stock: Geopolitical Turmoil Offers Growth Opportunities (NYSE:RTX)

This article was written by Follow I’m a passionate investor from the Netherlands with 12 years…

AstraZeneca’s Innovation Ecosystem: From Blockbusters To Next Generation Of Therapy (AZN)

This article was written by Follow My professional background spans multiple continents and includes experience in…

ECH ETF: Hopes On November Elections Might Lead To High Gains At High Risk (BATS:ECH)

This article was written by Follow My main area of interest is algorithmic trading and trading…

IBM: Is The Stock Price Overvalued? (NYSE:IBM)

This article was written by Follow Khaveen Investments is a Macroquantamental Hedge Fund managing a portfolio…

Arcutis Biotherapeutics Stock: Zoryve’s Growth Impresses, Valuation Concern (NASDAQ:ARQT)

This article was written by Follow With a background as a RN, I analyze healthcare-related stocks…

SEC clarifies that most stablecoins are not securities

Stablecoin Tether and Circle’s USDC dominate the market. Justin Tallis | Afp | Getty Images The…

Gentex Corporation And Its Real Value (Rating Downgrade) (NASDAQ:GNTX)

This article was written by Follow Grant Gigliotti is the founder of Beat The Market Analyzer,…

Amazon: Tariffs Not A Problem, But Index Investors Are (Rating Downgrade) (NASDAQ:AMZN)

This article was written by Follow I’m Rob Isbitts, founder of Sungarden Investment Publishing. I run…

Sangamo Therapeutics: Scope Goes Beyond That Of Recent Eli Lilly Licensing Deal (SGMO)

This article was written by Follow Terry Chrisomalis is a private investor in the Biotech sector…

Maravai LifeSciences: Upside Not Likely In 2025, But Company Can Survive (NASDAQ:MRVI)

This article was written by Follow Edmund Ingham is a biotech consultant. He has been covering…

EV Company News For The Month Of March 2025

This article was written by Follow The Trend Investing group includes qualified financial personnel with a…

FDLO: A Resilient ETF For A Turbulent Market (NYSEARCA:FDLO)

This article was written by Follow Fred Piard, PhD. is a quantitative analyst and IT professional…

Overweighting Apple And Microsoft: A Strategic Play For Strong Risk-Adjusted Returns

This article was written by Follow I specialize in constructing investment portfolios aimed at generating additional…

Emerging markets fund on track for biggest drop since 2020 due to tariff fears

Traders work on the floor of the New York Stock Exchange (NYSE) on April 04, 2025…